Sun Pharma’s arm launches Generic Glumetza Tablets in US

25 Jul 2018 Evaluate

Sun Pharmaceutical Industries’ wholly owned subsidiary has launched the generic versions of Glumetza (metformin hydrochloride) extended release tablets, 500 mg and 1000 mg in the US.

These generic Metformin HCI extended release tablets, 500mg and 1000mg are therapeutic equivalents of Santarus Inc.’s Glumetza HCI extended release tablets, 500 mg and 1000 mg. The addressable market size is approximately $ 443 million for the 12 months ending April 2018, as per IQVIA.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1669.20 -31.35 (-1.84%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×